Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LTB4R | Q15722 | 7/20 | 0.34 |
| ▸ | LTB4R2 | Q9NPC1 | 6/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19804301 | 0.85 | CA1 (0.36) | POLBAPEX1HTTTDP1LTB4R | |
| SCHEMBL19804477 | 0.84 | ALOX5AP (0.41) | SLC6A9LTB4RLTB4R2KDM4E | |
| SCHEMBL19796396 | 0.84 | RARB (0.39) | POLBHTTTDP1KDM4ETHRB | |
| SCHEMBL19804373 | 0.80 | SLC6A9 (0.42) | SLC6A9POLBAPEX1HTTTDP1 | |
| SCHEMBL19804505 | 0.79 | CYP3A4 (0.39) | SLC6A9CA1CA2 | |
| SCHEMBL19804318 | 0.78 | SLC6A9 (0.36) | SLC6A9POLBAPEX1HTTTDP1 | |
| SCHEMBL19804421 | 0.78 | FEN1 (0.43) | SLC6A9LTB4RLTB4R2L3MBTL1 | |
| SCHEMBL19804347 | 0.77 | LTB4R (0.39) | SLC6A9POLBAPEX1HTTTDP1 | |
| SCHEMBL19804320 | 0.77 | PTGER4 (0.39) | POLBAPEX1HTTTDP1LTB4R | |
| SCHEMBL19804279 | 0.76 | ALOX5AP (0.43) | SLC6A9POLBAPEX1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | SLC6A9 2938/4885POLB 3105/4885APEX1 1385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.